James Wason
occupation: researcher
Articles 69
-
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials
-
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
-
Analysis of responder-based endpoints: improving power through utilising continuous components
-
Multisystemic therapy compared with management as usual for adolescents at risk of offending: the START II RCT
-
Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate
-
Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
-
Employing a latent variable framework to improve efficiency in composite endpoint analysis
-
Design of experiments for a confirmatory trial of precision medicine
-
Familywise error control in multi-armed response-adaptive trials
-
Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies
-
A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints
-
Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study
-
To add or not to add a new treatment arm to a multiarm study: A decision-theoretic framework
-
When to keep it simple - adaptive designs are not always useful
-
The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study
-
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis
-
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trial.
-
Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT.
-
Adaptive designs in clinical trials: why use them, and how to run and report them.
-
An optimised multi-arm multi-stage clinical trial design for unknown variance.
-
Improving the analysis of composite endpoints in rare disease trials.
-
Healthy Campus Trial: a multiphase optimization strategy (MOST) fully factorial trial to optimize the smartphone cognitive behavioral therapy (CBT) app for mental health promotion among university students: study protocol for a randomized controlled
-
Blinded and unblinded sample size reestimation procedures for stepped-wedge cluster randomized trials
-
A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol
-
Group sequential crossover trial designs with strong control of the familywise error rate
-
Admissible multiarm stepped-wedge cluster randomized trial designs
-
Blinded and unblinded sample size reestimation in crossover trials balanced for period
-
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
-
Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
-
Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
-
Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements
-
Group sequential designs for stepped-wedge cluster randomised trials.
Human - wd:Q60644055